الاتحاد الأوروبي - الألمانية - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).

الاتحاد الأوروبي - الألمانية - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza-virus-oberflächenantigene (hämagglutinin und neuraminidase) des stammes a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - impfstoffe - aktive immunisierung gegen den h5n1-subtyp des influenza a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

سويسرا - الألمانية - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - dexamethasonum, neomycinum, polymyxini b sulfas - augentropfen - dexamethasonum 1 mg, neomycinum 3.5 mg ut neomycini sulfas 4.6 mg, polymyxini b sulfas 6000 u.i., natrii chloridum, polysorbatum 20, acidum hydrochloridum aut natrii hydroxidum, hypromellosum, aqua purificata, benzalkonii chloridum 40 µg, ad suspensionem pro 1 ml. - infizierte augenentzündungen - synthetika

سويسرا - الألمانية - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ciclosporinum - kapseln - ciclosporinum 50 mg, ethanolum anhydricum 50 mg, propylenglycolum 50 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 202.5 mg, e 307, kapselhülle: titanii dioxidum, glycerolum (85 per centum), propylenglycolum 40.36 mg, gelatina, drucktinte: e 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % v/v. - immunsuppressivum - biotechnologika

سويسرا - الألمانية - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ciclosporinum - kapseln - ciclosporinum 10 mg, ethanolum anhydricum 10 mg, propylenglycolum 10 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 40.5 mg, e 307, kapselhülle: titanii dioxidum, glycerolum (85 per centum) 6.9 mg, propylenglycolum 10.8 mg, gelatina, drucktinte: e 120, aluminii chloridum hexahydricum, natrii hydroxidum, propylenglycolum, hypromellosum, pro capsula corresp. ethanolum 12 % v/v. - immunsuppressivum - biotechnologika

سويسرا - الألمانية - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - travoprostum - augentropfen - travoprostum 40 µg, macrogolglyceroli hydroxystearas 2 mg, propylenglycolum, acidum boricum, mannitolum, natrii chloridum, polyquaternium-1, acidum hydrochloridum aut natrii hydroxidum ad ph, aqua purificata q.s. ad solutionem pro 1 ml. - glaukom - synthetika

سويسرا - الألمانية - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - travoprostum, timololum - augentropfen - travoprostum 40 µg, timololum 5 mg ut timololi maleas, macrogolglyceroli hydroxystearas, propylenglycolum, acidum boricum, mannitolum, natrii chloridum, polyquaternium-1, acidum hydrochloridum aut natrii hydroxidum ad ph, aqua purificata, ad solutionem pro 1 ml. - okuläre hypertension, offenwinkelglaukom - synthetika

بلجيكا - الألمانية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma - ondansetron hydrochloride - injektionslösung - 2 mg/ml - ondansetron hydrochloride 10 mg - ondansetron

بلجيكا - الألمانية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma - ondansetron hydrochloride - injektionslösung - 2 mg/ml - ondansetron hydrochloride 5 mg - ondansetron

بلجيكا - الألمانية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma - everolimus - tablette zur herstellung einer suspension zum einnehmen - 0,10 mg - everolimus 0.1 mg - everolimus